Business Context and Reporting Period
Company: Laboratory Corporation of America Holdings (LabCorp)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008
Business Overview: LabCorp operates as a leading provider of clinical laboratory testing services. The reporting period includes the full consolidation of its Ontario, Canada joint venture (acquired effective January 1, 2008), which significantly impacts year-over-year comparisons. The quarter was also affected by severe weather events (Gulf Coast hurricanes) impacting specimen volume.
Key Financial Metrics
| Metric (in millions) | Three Months Ended Sept 30, 2008 | Nine Months Ended Sept 30, 2008 | Nine Months Ended Sept 30, 2007 |
|---|---|---|---|
| Net Sales | $1,135.1 | $3,386.1 | $3,062.4 |
| Gross Profit | $461.6 | $1,423.9 | $1,285.8 |
| Operating Income | $202.2 | $638.5 | $594.8 |
| Net Earnings | $111.9 | $346.4 | $362.4 |
| Diluted EPS | $1.00 | $3.06 | $2.95 |
| Cash from Operations (9mo) | $565.6 (2008) vs $469.3 (2007) | ||
| Total Debt (Current + Long-term) | $1,726.9 (Sept 30, 2008) | ||
| Cash and Equivalents | $49.4 (Sept 30, 2008) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11.2% in Q3 and 10.6% for the nine-month period. A significant portion of this growth ($59.4M in Q3; $190.5M in 9 months) is attributable to the consolidation of the Ontario joint venture. Excluding Ontario, organic growth was driven by a 3.1% increase in accession volume and 2.3% price increase in Q3.
- Profitability: Operating income rose to $202.2M in Q3 from $178.9M in the prior year. However, net earnings for the nine months decreased slightly to $346.4M from $362.4M, largely due to higher bad debt provisions and restructuring costs.
- Bad Debt Expense: The provision for doubtful accounts increased significantly ($45.0M in Q2 2008) due to economic conditions, higher patient deductibles, and co-payments. Bad debt expense as a percentage of net sales rose to 6.4% for the nine months ended Sept 30, 2008, compared to 4.8% in 2007.
- Restructuring Charges: The company recorded $12.2M in restructuring charges in Q3 2008 (vs. $31.3M in Q3 2007) and $28.2M for the nine months (vs. $38.3M in 2007). These charges relate to workforce reductions and facility closures.
- Joint Venture Income: Income from joint venture partnerships dropped significantly ($3.7M in Q3 2008 vs. $20.9M in Q3 2007) because the Ontario operation is now consolidated into operating results rather than reported as equity income.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects total capital expenditures for 2008 to be between $140.0M and $160.0M.
- Pension Outlook: Due to the decline in the fair value of plan assets in 2008, the company expects an increase in fiscal 2009 pension expense. Estimated contributions for 2009 are approximately $22.0M.
- Convertible Debt: Zero-coupon subordinated notes (LYONs and Zero-Coupon Notes) became convertible on October 1, 2008, through December 31, 2008. The company also announced contingent cash interest accruals for these notes.
- Liquidity and Credit Facilities: Lehman Brothers Holdings, a lender with a $28.0M commitment in the company's revolving facility, filed for bankruptcy. The company does not expect Lehman to fulfill future borrowing requests and is evaluating options. The company remains in compliance with all debt covenants.
- UnitedHealthcare Agreement: The company is amortizing transition costs related to its exclusive national laboratory provider agreement with UnitedHealthcare. Total estimated reimbursement commitment is approximately $115.0M.
- Legal Proceedings: The company is involved in various legal matters, including a patent case (Competitive Technologies) where a judgment was entered in the company's favor in August 2008 (plaintiffs appealed), and ongoing government inquiries regarding billing practices. Management does not expect these to have a material adverse effect.
Investor Verification Checklist
- Ontario Consolidation Impact: Verify the extent to which revenue and margin growth is driven by the Ontario acquisition versus organic performance.
- Bad Debt Trends: Monitor the allowance for doubtful accounts and collection rates, given the 6.4% bad debt expense ratio and economic headwinds.
- Convertible Note Conversion: Assess the potential dilution or cash outflow if holders exercise the conversion option on the zero-coupon notes by December 31, 2008.
- Lehman Brothers Exposure: Confirm the company's ability to access its full revolving credit facility given the Lehman bankruptcy and the $28.0M gap.
- Pension Funding: Track the actual 2009 pension expense and contribution requirements, which are sensitive to fourth-quarter market performance.
- Restructuring Savings: Verify the realization of the estimated $59.0M in annualized cost savings from restructuring initiatives.